Event at-a-glance
The Pharma Cleaning and Containment Summit 2026 organized by Veridon Global, taking place from 20–22 May 2026 in Milan, Italy, is a high-level industry event focused on the evolving demands of cleaning validation, containment engineering, and cross-contamination control in pharmaceutical and biopharmaceutical manufacturing.
As the sector continues to embrace high-potency APIs, continuous manufacturing, and multi-product facilities, the need for robust, compliant, and efficient cleaning and containment systems has never been more urgent. This summit brings together global experts from manufacturing, quality, EHS, engineering, and regulatory affairs to explore the latest guidance, technologies, and best practices in the field.
Expect insightful presentations, real-world case studies, and interactive sessions on topics such as barrier systems, isolator technology, cleaning validation lifecycle, occupational exposure strategies, and risk-based approaches to facility design. Attendees will gain practical knowledge to enhance safety, ensure compliance, and optimize operations in high-risk manufacturing environments.
Whether you’re looking to benchmark strategies, source solutions, or stay ahead of regulatory shifts, the Pharma Cleaning and Containment Summit 2026 is your go-to platform for collaboration, learning, and innovation in this critical area of pharmaceutical production.
Key Topics
- Cleaning validation lifecycle & continued process verification
- Cross-contamination control in multi-product facilities
- Containment design for HPAPI and cytotoxic compounds
- Barrier systems, isolators, and closed processing innovations
- Risk-based approaches to cleaning and containment
- Regulatory updates: EMA, FDA, PIC/S, ISPE guidance
- OELs, occupational safety, and toxicological risk assessment
- Cleaning strategies for single-use and hybrid systems
- Automated cleaning systems and digital validation tools
- Case studies on cleaning failures and lessons learned
Why join us?
- Get clarity on evolving EMA, FDA, and PIC/S guidelines specific to cleaning validation, HPAPI containment, and cross-contamination control in multi-product facilities.
- Learn how leading manufacturers are managing cleaning in high-potency and cytotoxic settings, validating cleaning effectiveness, and designing safe, compliant containment systems.
- See how the latest isolators, barrier systems, and automated cleaning technologies are transforming the design and operation of high-containment manufacturing environments.
- Compare approaches to cleaning validation lifecycle, visual inspection standards, cleaning hold times, and cleaning of single-use versus stainless steel systems.
- Network with peers and solution providers dealing with the same critical challenges in HPAPI handling, OEL compliance, operator safety, and facility risk assessments.
Target Audience
- Pharmaceutical and Biotech Companies: Executives, decision-makers, and researchers involved in drug development, market access, and pricing strategies.
- Regulators and Policy Makers – Representatives from healthcare authorities, regulatory bodies, and health technology assessment (HTA) agencies across Europe.
- Researchers– Experts using RWE to assess treatment outcomes, improve healthcare models, and support regulatory submissions.
- Advisors and Payers – Professionals providing guidance on pricing strategies, reimbursement, and RWE implementation.
- Investors – Individuals and firms interested in funding innovation in healthcare, particularly in RWE and value-based pricing models.
Speakers (TBA)
Sponsors
Gold Sponsor
